RCG
AGN

Ruane, Cunniff & Goldfarb’s Allergan plc AGN Stock Holding History

Ruane, Cunniff & Goldfarb’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-3,075
Closed -$708K – 106
2016
Q3 		$708K Sell
3,075
-360
-10% -$88K 0.01% 85
2016
Q2 		$794K Sell
3,435
-1,022,120
-100% -$236M 0.01% 86
2016
Q1 		$275M Sell
1,025,555
-60,315
-6% -$17.3M 2.14% 13
2015
Q4 		$339M Sell
1,085,870
-17,525
-2% -$5.22M 1.93% 13
2015
Q3 		$300M Buy
+1,103,395
New +$339M 1.54% 13

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Ruane, Cunniff & Goldfarb's AGN Position: Q4 2016 in Review

Ruane, Cunniff & Goldfarb sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 3,075 shares — an estimated $708K sold.

Ruane, Cunniff & Goldfarb first reported a position in AGN in Q3 2015 and held it in 5 quarters. The position peaked at $339M in Q4 2015. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Ruane, Cunniff & Goldfarb reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • Ruane, Cunniff & Goldfarb sold 3,075 Allergan plc shares in Q4 2016, an estimated $708K.
  • Ruane, Cunniff & Goldfarb first reported a position in Allergan plc in Q3 2015 and held it in 5 quarters.
  • Ruane, Cunniff & Goldfarb's Allergan plc position peaked at $339M in Q4 2015.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Ruane, Cunniff & Goldfarb's 13F filing for Q4 2016, filed 13 Feb 2017.